PhD
Associate Professor, Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy
Joint Biomedical Engineering Department, UNC and NCSU
UNC-Chapel Hill and NC State University
Cancer Cell Biology Research Program
Area of Interest
The Brudno lab focuses on exploiting cutting edge chemistry and material science technologies to understand physiological responses during disease and fulfill critical unmet needs in the clinic. Our group develops new biomaterials for therapeutic cell production and delivery and drug delivery, with a focus on cancer immunotherapy and CAR T cell therapy. Our lab’s research is rooted in the belief that advances in chemistry and the basic molecular sciences can generate meaningful change in how therapies are designed, produced, and administered.
Awards and Honors
- Fellow, American Institute for Medical and Biological Engineering
- University Faculty Scholar
- Goodnight Early Career Innovator Award
- Outstanding Teacher Award
- NCI MERIT Award
News and Stories
Freeman, Brudno named AIMBE fellows
UNC Lineberger's Ronit Freeman, PhD, and Yevgeny Brudno, PhD, were inducted as fellows of the American Institute for Medical and Biological Engineering, one of the highest honors for researchers in this field. Four UNC faculty members received the honor.
UNC thinktank engineers immune cells to target brain cancer
Kristy Ainslie, PhD, and colleagues were awarded a $12.8 million NIH Program Project grant to form a collaborative team researching biomaterials to boost the body’s own immune system to enhance cell-based immunotherapy to fight glioblastoma.
